Myocardin and Stat3 act synergistically to inhibit cardiomyocyte apoptosis

4Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Signal transducer and activator of transcription 3 (Stat3) and Myocardin regulate cardiomyocyte differentiation, proliferation, and apoptosis. We report a novel aspect of the cellular function of Myocardin and Stat3 in the regulation of cardiomyocyte apoptosis. Myocardin and Stat3 showed anti-apoptotic function by increasing the expression of Bcl-2 while reducing expression of the pro-apoptotic genes Bax, Apaf- 1, caspase-9, and caspase-3. Moreover, myocardin/Stat3-mediated activation of Bcl-2 and Mcl-1 transcription is contingent on the CArG box. Myocardin and Stat3 synergistically inhibited staurosporine-induced cardiomyocyte apoptosis by upregulating expression of anti-apoptotic Bcl-2 and Mcl-1 in neonatal rat cardiomyocytes. These results describe a novel anti-apoptotic Myocardin/Stat3 signaling pathway operating during cardiomyocyte apoptosis. This provides a molecular explanation for cardiomyocyte apoptosis inhibition as a critical component of myocardial protection.

Cite

CITATION STYLE

APA

Xiang, Y., Liao, X. H., Li, J. P., Li, H., Qin, H., Yao, A., … Zhang, T. C. (2017). Myocardin and Stat3 act synergistically to inhibit cardiomyocyte apoptosis. Oncotarget, 8(59), 99612–99623. https://doi.org/10.18632/oncotarget.20450

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free